The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome

NCT06869824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2025-07-03

No results posted yet for this study

Summary

The goal of this randomized, double-blind, placebo controlled study is to learn about the efficacy of Minayo Iron-rich Nutritional Gummies on females who are aged 18-45 and suffer nutritional Anemia, skin condition and Qi-blood deficiency syndrome. The main question it aims to answer is:

\- whether the Anemia (measured by serum ferritin level and hemoglobin concentration Level in blood) is improved after the intervention

36 qualified participants will be enrolled and assigned to two equal-size groups with study product (Minayo Iron-rich Nutritional Gummies) and placebo product (common gummies) in one study center in Shanghai. The study will last 4 weeks and three site visits will be made, during which all clinical data will be captured and entered to EDC system for statistical analysis and reporting.

Researchers will find out whether the study product (Minayo Iron-rich Nutritional Gummies) is effective to improve Anemia, skin conditions, and Qi-blood deficiency symptoms by comparing the two groups.

Conditions

  • Anemia
  • Skin Condition
  • Qi-blood Deficiency Syndrome

Interventions

DIETARY_SUPPLEMENT

Minayo Iron-rich Nutritional Gummies

Participants need to eat one piece of the assigned product after meal three times a day, for 4 consecutive weeks.

DIETARY_SUPPLEMENT

Common Gummies

Participants need to eat one piece of the assigned product after meal three times a day, for 4 consecutive weeks.

Sponsors & Collaborators

  • Hangzhou Agile Groups Network Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Charlie Zhang, MD · Raison Biotech Co., Ltd

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-17
Primary Completion
2025-04-13
Completion
2025-04-13

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06869824 on ClinicalTrials.gov